#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hodgkin's disease recurrent Chronic graft versus host disease in intestine Vernal keratoconjunctivitis Primary myelofibrosis Pseudomyxoma peritonei Trigeminal neuralgia Astrocytoma Hepatitis D Chronic kidney disease Endometrial adenocarcinoma Non-Hodgkin's lymphoma Solitary fibrous tumour Paraganglion neoplasm Myocarditis Neurofibromatosis More trials…

    Learn about Rare Diseases

    Amyotrophic lateral sclerosis – Diagnostics Niemann-Pick disease – Basic Information Friedreich’s ataxia – Trials in Disease Antisynthetase syndrome Marginal zone lymphoma refractory Angiosarcoma – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Life with Disease Urea cycle disorder Congenital hypotransferrinaemia – Basic Information Glomerulonephritis rapidly progressive – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gsk4004280 Sodium Chloride Solution 0.9% Ribitol Tazemetostat Carfilzomib Dronabinol Lactose Gskvx000000008866 Jnj-64042056 ARFOLITIXORIN Roflumilast Vildagliptin ACETYLCARNITINE HYDROCHLORIDE Corline Heparin Conjugate Isoflurane Ontasameran Clindamycin Tulmimetostat Ptg-Carcik-Cd19 Belimumab More therapies…

    Learn about Your Condition

    Foetal growth restriction Gastrectomy Hypochromic anaemia Adenocarcinoma gastric Osteosarcoma metastatic Testicular germ cell tumour Thyroid disorder Food allergy Myeloproliferative neoplasm Pulmonary alveolar haemorrhage Coagulopathy Crohn's disease Hepatocellular carcinoma Double hit lymphoma Breast angiosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Reproductive and Urinary Physiological Phenomena

  • Study on Botulinum Toxin Type A for Adults with Chronic Pelvic Pain Syndrome (CPPS)

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A
    Italy

  • Study on Vitamin D Supplementation (Colecalciferol) and Its Effect on Urinary Calcium Levels in Children and Teens Aged 2 to 18 Years

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Colecalciferol
    France

  • Study on the Safety of Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells for Patients with Recurrent Urethral Stricture

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Urethral stenosis
    Investigated Drugs:
    • Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells
    France

  • Study on the Effectiveness of Carboplatin and Paclitaxel in Treating Cervical Cancer with Para-aortic Lymph Node Involvement

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cervix carcinoma stage III
    • Cervix carcinoma stage IV
    • Cervix carcinoma
    Investigated Drugs:
    • Carboplatin
    • Paclitaxel
    France

  • Effect of iclepertin on the blood levels of ethinylestradiol and levonorgestrel in healthy premenopausal women

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Ethinylestradiol
    • Iclepertin
    • Levonorgestrel
    Germany

  • A study on ovulation inhibition with norelgestromin patch after missed applications in women who need birth control

    Not recruiting

    2 1 1
    Investigated Drugs:
    • NORELGESTROMIN
    Germany
Previous Page
1 2 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!